NEUROTERA: For the placing on the market of new therapeutic agents against ocular and cerebral comorbidities associated with paramyloidosis (Q2907213): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed label, description and/or aliases in en: Setting new description)
(‎Added qualifier: readability score (P590521): 0.000011549073841409742)
 
(16 intermediate revisions by the same user not shown)
label / enlabel / en
 
NEUROTERA: For the placing on the market of new therapeutic agents against ocular and cerebral comorbidities associated with paramyloidosis
label / frlabel / fr
 
NEUROTERA: Pour la mise sur le marché de nouveaux agents thérapeutiques contre les comorbidités oculaires et cérébrales associées à la paramylose
label / delabel / de
 
NEUROTERA: Für das Inverkehrbringen neuer therapeutischer Mittel gegen okuläre und zerebrale Komorbiditäten im Zusammenhang mit Paramyloidose
label / nllabel / nl
 
NEUROTERA: Voor het in de handel brengen van nieuwe therapeutische middelen tegen oculaire en cerebrale comorbiditeiten in verband met paramyloïdose
label / itlabel / it
 
NEUROTERA: Per l'immissione in commercio di nuovi agenti terapeutici contro le comorbidità oculari e cerebrali associate alla paramiloidosi
label / eslabel / es
 
NEUROTERA: Para la comercialización de nuevos agentes terapéuticos contra las comorbilidades oculares y cerebrales asociadas a la paramiloidosis
label / etlabel / et
 
NEUROTERA: Paramüloidoosiga seotud silma- ja ajukomorbiidide vastaste uute ravimite turuleviimiseks
label / ltlabel / lt
 
NEUROTERA: Dėl naujų terapinių preparatų nuo akių ir smegenų gretutinių ligų, susijusių su paramiloidoze, pateikimo į rinką
label / hrlabel / hr
 
NEUROTERA: Za stavljanje na tržište novih terapijskih sredstava protiv očnih i cerebralnih komorbiditeta povezanih s paramiloidozom
label / ellabel / el
 
NEUROTERA: Για τη διάθεση στην αγορά νέων θεραπευτικών παραγόντων κατά των οφθαλμικών και εγκεφαλικών συννοσηροτήτων που συνδέονται με την παραμυλοείδωση
label / sklabel / sk
 
NEUROTERA: Na uvádzanie nových terapeutických látok proti očným a mozgovým komorbiditám spojeným s paramyloidózou na trh
label / filabel / fi
 
NEUROTERA: Uusien terapeuttisten aineiden markkinoille saattamisesta paramyloidoosiin liittyviä silmä- ja aivosairautta vastaan
label / pllabel / pl
 
NEUROTERA: Do wprowadzania do obrotu nowych leków przeciw chorobom współistniejącym okulistycznym i mózgowym związanym z paramyloidozą
label / hulabel / hu
 
NEUROTERA: Paramyloidosissal összefüggő szemészeti és agyi komorbiditások elleni új terápiás szerek forgalomba hozatalához
label / cslabel / cs
 
NEUROTERA: Pro uvedení nových terapeutických prostředků proti očním a mozkovým komorbiditám spojeným s paramyloidózou na trh
label / lvlabel / lv
 
NEUROTERA: Jaunu terapeitisku līdzekļu laišanai tirgū pret acu un smadzeņu blakusslimībām, kas saistītas ar paramiloidozi
label / galabel / ga
 
NEUROTERA: Chun oibreáin theiripeacha nua a chur ar an margadh in aghaidh comorbidities ocular agus ceirbreach a bhaineann le paramyloidosis
label / sllabel / sl
 
NEUROTERA: Za dajanje v promet novih zdravil proti očesnim in možganskim komorbidom, povezanim s paramiloidozo
label / bglabel / bg
 
NEUROTERA: За пускане на пазара на нови терапевтични агенти срещу очни и мозъчни коморбиди, свързани с парамилоидоза
label / mtlabel / mt
 
NEUROTERA: Għat-tqegħid fis-suq ta’ aġenti terapewtiċi ġodda kontra l-komorbiditajiet okulari u ċerebrali assoċjati mal-paramilojdosi
label / dalabel / da
 
EUROTERA: Til markedsføring af nye terapeutiske midler mod øjen- og cerebral comorbiditet i forbindelse med paramyloidose
label / rolabel / ro
 
NEUROTERA: Pentru introducerea pe piață a noilor agenți terapeutici împotriva comorbidităților oculare și cerebrale asociate cu paramiloidoza
label / svlabel / sv
 
NEUROTERA: För utsläppande på marknaden av nya terapeutiska medel mot okulära och cerebrala komorbiditeter i samband med paramyloidos
description / bgdescription / bg
 
Проект Q2907213 в Португалия
description / hrdescription / hr
 
Projekt Q2907213 u Portugalu
description / hudescription / hu
 
Projekt Q2907213 Portugáliában
description / csdescription / cs
 
Projekt Q2907213 v Portugalsku
description / dadescription / da
 
Projekt Q2907213 i Portugal
description / nldescription / nl
 
Project Q2907213 in Portugal
description / etdescription / et
 
Projekt Q2907213 Portugalis
description / fidescription / fi
 
Projekti Q2907213 Portugalissa
description / frdescription / fr
 
Projet Q2907213 au Portugal
description / dedescription / de
 
Projekt Q2907213 in Portugal
description / eldescription / el
 
Έργο Q2907213 στην Πορτογαλία
description / gadescription / ga
 
Tionscadal Q2907213 sa Phortaingéil
description / itdescription / it
 
Progetto Q2907213 in Portogallo
description / lvdescription / lv
 
Projekts Q2907213 Portugālē
description / ltdescription / lt
 
Projektas Q2907213 Portugalijoje
description / mtdescription / mt
 
Proġett Q2907213 fil-Portugall
description / pldescription / pl
 
Projekt Q2907213 w Portugalii
description / ptdescription / pt
 
Projeto Q2907213 em Portugal
description / rodescription / ro
 
Proiectul Q2907213 în Portugalia
description / skdescription / sk
 
Projekt Q2907213 v Portugalsku
description / sldescription / sl
 
Projekt Q2907213 na Portugalskem
description / esdescription / es
 
Proyecto Q2907213 en Portugal
description / svdescription / sv
 
Projekt Q2907213 i Portugal
Property / budget
891,220.51 Euro
Amount891,220.51 Euro
UnitEuro
 
Property / budget: 891,220.51 Euro / rank
Normal rank
 
Property / co-financing rate
66.0 percent
Amount66.0 percent
Unitpercent
 
Property / co-financing rate: 66.0 percent / rank
Normal rank
 
Property / beneficiary name (string)
BSIM THERAPEUTICS, S.A.
 
Property / beneficiary name (string): BSIM THERAPEUTICS, S.A. / rank
Normal rank
 
Property / summary
 
None (Estonian)
Property / summary: None (Estonian) / rank
 
Normal rank
Property / summary: None (Estonian) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Lithuanian)
Property / summary: None (Lithuanian) / rank
 
Normal rank
Property / summary: None (Lithuanian) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Italian)
Property / summary: None (Italian) / rank
 
Normal rank
Property / summary: None (Italian) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (French)
Property / summary: None (French) / rank
 
Normal rank
Property / summary: None (French) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Croatian)
Property / summary: None (Croatian) / rank
 
Normal rank
Property / summary: None (Croatian) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Greek)
Property / summary: None (Greek) / rank
 
Normal rank
Property / summary: None (Greek) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (English)
Property / summary: None (English) / rank
 
Normal rank
Property / summary: None (English) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary: None (English) / qualifier
 
readability score: 0.000011549073841409742
Amount0.000011549073841409742
Unit1
Property / summary
 
None (Slovak)
Property / summary: None (Slovak) / rank
 
Normal rank
Property / summary: None (Slovak) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Finnish)
Property / summary: None (Finnish) / rank
 
Normal rank
Property / summary: None (Finnish) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Polish)
Property / summary: None (Polish) / rank
 
Normal rank
Property / summary: None (Polish) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Hungarian)
Property / summary: None (Hungarian) / rank
 
Normal rank
Property / summary: None (Hungarian) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Dutch)
Property / summary: None (Dutch) / rank
 
Normal rank
Property / summary: None (Dutch) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Czech)
Property / summary: None (Czech) / rank
 
Normal rank
Property / summary: None (Czech) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Latvian)
Property / summary: None (Latvian) / rank
 
Normal rank
Property / summary: None (Latvian) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Irish)
Property / summary: None (Irish) / rank
 
Normal rank
Property / summary: None (Irish) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Slovenian)
Property / summary: None (Slovenian) / rank
 
Normal rank
Property / summary: None (Slovenian) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Spanish)
Property / summary: None (Spanish) / rank
 
Normal rank
Property / summary: None (Spanish) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Bulgarian)
Property / summary: None (Bulgarian) / rank
 
Normal rank
Property / summary: None (Bulgarian) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Maltese)
Property / summary: None (Maltese) / rank
 
Normal rank
Property / summary: None (Maltese) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Portuguese)
Property / summary: None (Portuguese) / rank
 
Normal rank
Property / summary: None (Portuguese) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Danish)
Property / summary: None (Danish) / rank
 
Normal rank
Property / summary: None (Danish) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Romanian)
Property / summary: None (Romanian) / rank
 
Normal rank
Property / summary: None (Romanian) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (German)
Property / summary: None (German) / rank
 
Normal rank
Property / summary: None (German) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Swedish)
Property / summary: None (Swedish) / rank
 
Normal rank
Property / summary: None (Swedish) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / priority axis
 
Property / priority axis: Strengthening research, technological development and innovation (OT1) / rank
 
Normal rank
Property / thematic objective
 
Property / thematic objective: Research and innovation / rank
 
Normal rank
Property / beneficiary
 
Property / beneficiary: BSIM THERAPEUTICS, S.A. / rank
 
Normal rank
Property / beneficiary name (string)
 
BSIM THERAPEUTICS, S.A.
Property / beneficiary name (string): BSIM THERAPEUTICS, S.A. / rank
 
Normal rank
Property / budget
 
934,289.9 Euro
Amount934,289.9 Euro
UnitEuro
Property / budget: 934,289.9 Euro / rank
 
Preferred rank
Property / EU contribution
 
722,832.3 Euro
Amount722,832.3 Euro
UnitEuro
Property / EU contribution: 722,832.3 Euro / rank
 
Preferred rank
Property / co-financing rate
 
77.37 percent
Amount77.37 percent
Unitpercent
Property / co-financing rate: 77.37 percent / rank
 
Normal rank
Property / date of last update
 
14 November 2023
Timestamp+2023-11-14T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / date of last update: 14 November 2023 / rank
 
Normal rank

Latest revision as of 13:21, 20 March 2024

Project Q2907213 in Portugal
Language Label Description Also known as
English
NEUROTERA: For the placing on the market of new therapeutic agents against ocular and cerebral comorbidities associated with paramyloidosis
Project Q2907213 in Portugal

    Statements

    0 references
    722,832.3 Euro
    0 references
    934,289.9 Euro
    0 references
    77.37 percent
    0 references
    16 August 2016
    0 references
    15 February 2020
    0 references
    BSIM THERAPEUTICS, S.A.
    0 references
    None (Estonian)
    29 July 2022
    0 references
    None (Lithuanian)
    29 July 2022
    0 references
    None (Italian)
    29 July 2022
    0 references
    None (French)
    29 July 2022
    0 references
    None (Croatian)
    29 July 2022
    0 references
    None (Greek)
    29 July 2022
    0 references
    None (English)
    29 July 2022
    0.000011549073841409742
    0 references
    None (Slovak)
    29 July 2022
    0 references
    None (Finnish)
    29 July 2022
    0 references
    None (Polish)
    29 July 2022
    0 references
    None (Hungarian)
    29 July 2022
    0 references
    None (Dutch)
    29 July 2022
    0 references
    None (Czech)
    29 July 2022
    0 references
    None (Latvian)
    29 July 2022
    0 references
    None (Irish)
    29 July 2022
    0 references
    None (Slovenian)
    29 July 2022
    0 references
    None (Spanish)
    29 July 2022
    0 references
    None (Bulgarian)
    29 July 2022
    0 references
    None (Maltese)
    29 July 2022
    0 references
    None (Portuguese)
    29 July 2022
    0 references
    None (Danish)
    29 July 2022
    0 references
    None (Romanian)
    29 July 2022
    0 references
    None (German)
    29 July 2022
    0 references
    None (Swedish)
    29 July 2022
    0 references
    14 November 2023
    0 references

    Identifiers

    POCI-01-0247-FEDER-003431
    0 references